Structural Modifications of (Z)-3-(2-aminoethyl)-5-(4-ethoxybenzylidene)thiazolidine-2,4-dione that Improve Selectivity for the Inhibition of Melanoma Cells Containing Active ERK Signaling
dc.contributor.author | Jung, Kwan-Young | |
dc.contributor.author | Samadani, Ramin | |
dc.contributor.author | Chauhan, Jay | |
dc.contributor.author | Nevels, Kerrick | |
dc.contributor.author | Yap, Jeremy L. | |
dc.contributor.author | Zhang, Jun | |
dc.contributor.author | Worlikar, Shilpa | |
dc.contributor.author | Lanning, Maryanna E. | |
dc.contributor.author | Chen, Lijia | |
dc.contributor.author | Ensey, Mary | |
dc.contributor.author | Shukla, Sagar | |
dc.contributor.author | Salmo, Rosene | |
dc.contributor.author | Heinzl, Geoffrey | |
dc.contributor.author | Gordon, Caryn | |
dc.contributor.author | Dukes, Troy | |
dc.contributor.author | MacKerell, Alexander D., Jr. | |
dc.contributor.author | Shapiro, Paul | |
dc.contributor.author | Fletcher, Steven | |
dc.contributor.department | Pharmacology and Toxicology, School of Medicine | |
dc.date.accessioned | 2025-05-09T12:03:57Z | |
dc.date.available | 2025-05-09T12:03:57Z | |
dc.date.issued | 2013 | |
dc.description.abstract | We herein report on the pharmacophore determination of the ERK docking domain inhibitor (Z)-3-(2-aminoethyl)-5-(4-ethoxybenzylidene)thiazolidine-2,4-dione, which has led to the discovery of compounds with greater selectivities for inhibiting the proliferation of melanoma cells containing active ERK signaling. | |
dc.eprint.version | Author's manuscript | |
dc.identifier.citation | Jung KY, Samadani R, Chauhan J, et al. Structural modifications of (Z)-3-(2-aminoethyl)-5-(4-ethoxybenzylidene)thiazolidine-2,4-dione that improve selectivity for inhibiting the proliferation of melanoma cells containing active ERK signaling. Org Biomol Chem. 2013;11(22):3706-3732. doi:10.1039/c3ob40199e | |
dc.identifier.uri | https://hdl.handle.net/1805/47925 | |
dc.language.iso | en_US | |
dc.publisher | Royal Society of Chemistry | |
dc.relation.isversionof | 10.1039/c3ob40199e | |
dc.relation.journal | Organic & Biomolecular Chemistry | |
dc.rights | Publisher Policy | |
dc.source | PMC | |
dc.subject | Antineoplastic agents | |
dc.subject | Melanoma | |
dc.subject | Thiazolidinediones | |
dc.title | Structural Modifications of (Z)-3-(2-aminoethyl)-5-(4-ethoxybenzylidene)thiazolidine-2,4-dione that Improve Selectivity for the Inhibition of Melanoma Cells Containing Active ERK Signaling | |
dc.type | Article |